Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$445M |
| 2 |
iShares 10-20 Year Treasury Bond ETF
TLH
|
+$354M |
| 3 |
Electronic Arts
EA
|
+$337M |
| 4 |
Procter & Gamble
PG
|
+$249M |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$205M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$351M |
| 2 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$344M |
| 3 |
Eli Lilly
LLY
|
+$310M |
| 4 |
Hershey
HSY
|
+$308M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$280M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.03% |
| 2 | Healthcare | 12.58% |
| 3 | Financials | 11.51% |
| 4 | Industrials | 8.61% |
| 5 | Consumer Discretionary | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Akebia Therapeutics
AKBA
$338M
| $52K | ﹤0.01% |
164,835
+153,637
| +1,372% | +$60.3K |
|
3827
Senseonics Holdings Inc
SENS
$254M
| $52K | ﹤0.01% |
1,958
+1,115
| +132% | +$34.1K |
|
3828
Virgin Galactic
SPCE
$315M
| $50K | ﹤0.01% |
533
-442
| -45% | -$56.7K |
|
|
TELL
3829
DELISTED
Tellurian Inc.
TELL
| $45K | ﹤0.01% |
18,778
+1,077
| +6% | +$3.88K |
|
|
NAGE
3830
Niagen Bioscience
NAGE
$256M
| $44K | ﹤0.01% |
35,384
-10,300
| -23% | -$16.6K |
|
3831
MediciNova
MNOV
$63.5M
| $42K | ﹤0.01% |
19,300
-6,200
| -24% | -$14.4K |
|
|
LYLT
3832
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
| $42K | ﹤0.01% |
34,441
-54,459
| -61% | -$141K |
|
3833
iQIYI
IQ
$1.19B
| $40K | ﹤0.01% |
14,883
-3,147
| -17% | -$11.7K |
|
3834
Vroom Inc
VRM
$36.4M
| $40K | ﹤0.01% |
429
-169
| -28% | -$22.6K |
|
3835
Usio Inc
USIO
$54.4M
| $39K | ﹤0.01% |
30,200
-18,300
| -38% | -$33.5K |
|
|
ADVM
3836
DELISTED
Adverum Biotechnologies
ADVM
| $38K | ﹤0.01% |
+4,039
| New | +$53.1K |
|
|
CAN
3837
Canaan Creative
CAN
$172M
| $38K | ﹤0.01% |
+11,482
| New | +$41.9K |
|
|
ICVX
3838
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $38K | ﹤0.01% |
+12,102
| New | +$75.7K |
|
|
FIRY
3839
Firy Inc
FIRY
$154M
| $37K | ﹤0.01% |
1,797
-3,284
| -65% | -$92.6K |
|
|
IMDX
3840
Insight Molecular Diagnostics
IMDX
$141M
| $34K | ﹤0.01% |
2,295
+1,605
| +233% | +$27.8K |
|
3841
LifeMD
LFMD
$176M
| $33K | ﹤0.01% |
16,555
-28,405
| -63% | -$67.7K |
|
|
VBIV
3842
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $33K | ﹤0.01% |
1,557
-320
| -17% | -$8.63K |
|
3843
Oxbridge Re Holdings
OXBR
$11.2M
| $32K | ﹤0.01% |
15,000
| – | – |
|
|
AGTC
3844
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $31K | ﹤0.01% |
115,100
-9,400
| -8% | -$4.1K |
|
|
AUD
3845
DELISTED
Audacy, Inc.
AUD
| $29K | ﹤0.01% |
73,770
-24,808
| -25% | -$15K |
|
3846
Orion Group Holdings
ORN
$368M
| $27K | ﹤0.01% |
10,100
| – | – |
|
|
NNDM
3847
Nano Dimension
NNDM
$314M
| $26K | ﹤0.01% |
11,005
-95
| -0.9% | -$290 |
|
|
BTTX
3848
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
| $26K | ﹤0.01% |
+15,000
| New | +$27.4K |
|
3849
CuriosityStream
CURI
$148M
| $24K | ﹤0.01% |
16,272
-46,174
| -74% | -$81K |
|
3850
Goldgroup Mining Inc.
GORO
$155M
| $22K | ﹤0.01% |
13,418
+74
| +0.6% | +$126 |
|
Similar funds
Ameriprise's Q3 2022 Portfolio in Review
As of Q3 2022, Ameriprise held 4,097 positions worth $270B, down 5.7% from $287B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Ameriprise's Q3 2022 filing shows 218 new, 1,662 increased, 1,949 reduced and 144 closed positions. Its largest new stake was Pacer Lunt Large Cap Alternator ETF: 652,979 shares worth $23.4M. The largest sale was RTX Corp, an estimated $351M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q3 2022 buy was Pacer Lunt Large Cap Alternator ETF: 652,979 shares worth $23.4M.
- Ameriprise added most to Microchip Technology in Q3 2022, an estimated $445M increase.
- Ameriprise's biggest Q3 2022 reduction was RTX Corp, cutting an estimated $351M.
- Ameriprise fully exited VanEck Emerging Markets High Yield Bond ETF in Q3 2022, selling an estimated $49.5M.
- Ameriprise's ten largest holdings make up 14% of its $270B portfolio in Q3 2022.
- Ameriprise opened 218 new positions and closed 144 in Q3 2022.
- Ameriprise's portfolio value fell 5.7% quarter-over-quarter to $270B.
Based on Ameriprise's 13F filing for Q3 2022, filed 14 Nov 2022.